Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone versus dexmedetomidine as adjuvants to bupivacaine in pediatric erector spinae plane block for PCNL
PACTR202405917072685Phase 2Not yet recruiting
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bupivacaine, dexmedetomidine and dexamethasone in pain, sponsored by Kasr Al Ainy Hospital. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
bupivacainedexmedetomidinedexamethasone
03
Conditions
pain
Beyond the preview
Go deeper on PACTR202405917072685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202405917072685.